A Prospective Cohort Study of IRPF in China
Recruiting
Observational Study
Idiopathic Retroperitoneal Fibrosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 500 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a cohort study to investigate the disease course and treatment response of patients with idiopathic retroperitoneal fibrosis（IRPF）.
Methods: All the patients fulfilling diagnostic criteria of IRPF would be enrolled around China. A online database system will been established.
Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IRPF patients; the secon…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Males and females; 18-75 years old with informed consent; Patients diagnosed with definite or possible IRPF.
Exclusion Criteria:
Secondary forms of IRPF; Pregnant or Females planning to bear a child recently ; Concurrent severe and/or uncontrolled and/or unstable diseases; Pat…
Contacts